Central nervous system disease in acute lymphoblastic leukemia: prophylaxis and treatment.
about
In vitro and in vivo effects of free and chalcones-loaded nanoemulsions: insights and challenges in targeted cancer chemotherapiesA rare case of leptomeningeal carcinomatosis in a patient with uveal melanoma: case report and review of literature.Cognitive Sparing during the Administration of Whole Brain Radiotherapy and Prophylactic Cranial Irradiation: Current Concepts and Approaches.Central nervous system prophylaxis in adults with acute lymphoblastic leukemia: current and emerging therapies.Isolated central nervous system relapse of acute lymphoblastic leukemiaSNPs in the TGF-β signaling pathway are associated with increased risk of brain metastasis in patients with non-small-cell lung cancerNovel therapies for relapsed acute lymphoblastic leukemia.Breaking and entering into the CNS: clues from solid tumor and nonmalignant models with relevance to hematopoietic malignancies.Neurocognitive Predictors of Academic Outcomes Among Childhood Leukemia SurvivorsIncidence and risk factors for central nervous system relapse in children and adolescents with acute lymphoblastic leukemia.Treatment strategies and regimens of graduated intensity for childhood acute lymphoblastic leukemia in low-income countries: A proposal.Advances in individual prediction of methotrexate toxicity: a review.Persistent donor derived Vδ4 T cell clones may improve survival for recurrent T cell acute lymphoblastic leukemia after HSCT and DLIEmerging therapy for the treatment of acute lymphoblastic leukemia.Evaluation and Outcome of Central Nervous System Involvement in Pediatric Acute Lymphoblastic Leukemia in Dar es Salaam, Tanzania.The Role of the Central Nervous System Microenvironment in Pediatric Acute Lymphoblastic Leukemia.Aberrant microRNA-182 expression is associated with glucocorticoid resistance in lymphoblastic malignancies.Generation of Pediatric Leukemia Xenograft Models in NSG-B2m Mice: Comparison with NOD/SCID Mice.Cellular elements of the subarachnoid space promote ALL survival during chemotherapy.Comparative outcomes of Thai children with acute lymphoblastic leukemia treated with two consecutive protocols: 11-year experience.VE-cadherin and PECAM-1 enhance ALL migration across brain microvascular endothelial cell monolayers.MuLV-related endogenous retroviral elements and Flt3 participate in aberrant end-joining events that promote B-cell leukemogenesis.Strabismus and diplopia in a patient with acute myeloid leukemia.Effectiveness of modified hyper-CVAD chemotherapy regimen in the treatment of adult acute lymphoblastic leukemia: a retrospective experience.Primary central nervous system peripheral T-cell lymphoma in a child.Prolonged Survival of Acute Lymphoblastic Leukemia with Intrathecal Treatments for Isolated Central Nervous System Relapse.Lumbar spinal fluid collections in children treated with intrathecal chemotherapy: elevated CSF protein as a diagnostic clue.Initial presentation of CNS-restricted acute lymphoblastic B cell leukaemia as peripheral polyneuropathy.
P2860
Q30427531-3A96D0C1-2657-4F77-93D8-6F7695376A5CQ33885560-D9357C41-95AC-4B66-ABD4-F0F385FAEFC2Q34021952-4031936B-A734-405C-98ED-C908ECB00538Q34102628-5BC91A8A-CCFD-40C4-8D83-AC736ED9347AQ34509402-8F2CAB3E-72BC-4BF5-ACAF-8873FF66F47CQ34532211-DE23E873-862A-407B-A27D-4521177EE7A6Q34619129-E1D6A3A5-C29E-4F40-9838-A3B9D9A7B8E1Q35786301-9737B2C3-7AAD-4E85-8BFC-35F565E48DB3Q36445713-330A3FF5-A066-4381-926A-A44FB14E645FQ36534036-BA6477CF-FA02-4086-A5FF-9EC3F77F451DQ37363905-9A2E9D52-59AB-4800-998B-780F93620347Q37524415-6CB1FFDE-2B20-4C3C-8EEE-4C7E7D9A6CAEQ37536445-D81F8239-A151-405E-9027-4718011AB7D3Q37670194-8F2D4DAA-5BFE-493D-862E-73836672C45BQ38623368-605C8AE0-BCD5-4E4C-91B3-5D3AEDDD798AQ39297348-C9FCEBC0-F708-4EEB-93FB-D02D71DC5F28Q39348735-C4697A5E-DC28-4C12-8CA2-CCD3A5F339EBQ39571861-2F9C12EC-472D-4CF2-AFB9-6261FD2B1EB4Q39602322-684B9123-4B7B-490D-BBA1-0E1D89F93DB4Q39698824-A6AB8DB6-DEE6-4A62-AFF3-45016000FD06Q39703856-4BF79627-9D59-48DF-9263-929BC0CB9D3BQ40553965-E510D361-F2D4-42F5-A3BC-8A9C53FEE5F0Q41975577-BF293D13-C659-45D6-908E-3405110EFFBBQ48136104-EBF64B7C-1A7F-456D-944F-5207B011329BQ48145530-AB96A8F1-14BC-4987-858E-3DD5FB79FD5CQ52590712-72F2E140-5250-4715-B658-F9754C7C1EFDQ53479548-93F8B973-83C8-4A26-9787-E7823713E3BFQ55186201-519045FF-20EE-4E83-81CB-316121393A55
P2860
Central nervous system disease in acute lymphoblastic leukemia: prophylaxis and treatment.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Central nervous system disease ...... ia: prophylaxis and treatment.
@ast
Central nervous system disease ...... ia: prophylaxis and treatment.
@en
type
label
Central nervous system disease ...... ia: prophylaxis and treatment.
@ast
Central nervous system disease ...... ia: prophylaxis and treatment.
@en
prefLabel
Central nervous system disease ...... ia: prophylaxis and treatment.
@ast
Central nervous system disease ...... ia: prophylaxis and treatment.
@en
P1476
Central nervous system disease ...... ia: prophylaxis and treatment.
@en
P2093
Ching-Hon Pui
P304
P356
10.1182/ASHEDUCATION-2006.1.142
P577
2006-01-01T00:00:00Z